Buspirone is NOT effective for panic attacks and should not be used as a treatment for panic disorder.
Buspirone lacks FDA approval for panic disorder and has consistently failed to demonstrate efficacy superior to placebo in treating panic attacks. 1 The FDA labeling for buspirone does not include panic disorder as an indication, and multiple controlled trials have confirmed its ineffectiveness for this condition.
Evidence Against Buspirone for Panic Disorder
The research evidence is remarkably consistent and negative:
High-dose buspirone (mean 61 mg/day) was not superior to placebo on any outcome measure for panic attacks, anxiety, phobias, or disability in an 8-week controlled trial, while alprazolam showed clear superiority 2
Multiple controlled trials found no significant antipanic effect: Studies comparing buspirone to imipramine and placebo consistently showed buspirone failed to separate from placebo for panic frequency or panic-free status 3, 4
Even when buspirone was tested at doses up to 61 mg/day (substantially higher than the typical 15-30 mg/day used for generalized anxiety), it remained ineffective 2
Limited Adjunctive Role Only
The only potential use is as an adjunctive agent for residual generalized anxiety in patients already stabilized on benzodiazepines or other antipanic medications:
One small case series (n=4) suggested buspirone might help persistent generalized anxiety when added to benzodiazepines, though it did not treat the panic attacks themselves 5
When combined with cognitive behavioral therapy, buspirone showed some benefit for generalized anxiety and agoraphobia, but this was in the context of structured psychotherapy 6
What to Use Instead
For panic disorder, evidence-based first-line treatments include:
- SSRIs (sertraline, fluoxetine, paroxetine) - FDA-approved with strong efficacy data
- SNRIs (venlafaxine) - demonstrated effectiveness 7
- Benzodiazepines (alprazolam, clonazepam) - rapid onset but dependency concerns
- Cognitive behavioral therapy - either alone or combined with medication 7
Common Pitfall to Avoid
Do not prescribe buspirone assuming it will work for panic disorder simply because it's labeled as an "anxiolytic." Buspirone's mechanism (5-HT1A partial agonist) is effective for generalized anxiety disorder but does not address the neurobiological substrate of panic attacks. This is a critical distinction that prevents inappropriate treatment delays.